Open Access

New antidiabetic agents reduce cardiovascular events.

Congress Presentation

About the speaker

Associate Professor Jean-Paul Schmid

Clinic Gais AG, Gais (Switzerland)
24 presentations
0 follower

3 more presentations in this session

Distribution of estimated 10-year risk of recurrent vascular events and residual risk in a secondary prevention population.

Speaker: Professor F. Visseren (Utrecht, NL)

Thumbnail

Individual decision for length of dual antiplatelet therapy after ACS.

Speaker: Professor P. Clemmensen (Hamburg, DE)

Thumbnail

PCSK9-Inhibitions: for whom, when, and how effective.

Speaker: Professor C. Saely (Feldkirch, AT)

Thumbnail

Access the full session

Secondary Prevention: unmet medical needs - Session I

Speakers: Associate Professor J. Schmid, Professor F. Visseren, Professor P. Clemmensen, Professor C. Saely
Thumbnail

About the event

Image

EuroPrevent 2017

6 April - 8 April 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb